Evidence map›Paper›PMID 35466197›Full record

ArticleInternational journal of neonatal screening2022

Need and Viability of Newborn Screening Programme in India: Report from a Pilot Study.

Arya Raveendran, Teena Joseph Chacko, Priya Prabhu, Raghava Varma, Leslie Edward Lewis, Pragna Rao, Prajna P Shetty, Yajna S Phaneendra Mallimoggala, Asha Hedge, Dinesh M Nayak and 2 more

Abstract read
In one paragraph

Article in International journal of neonatal screening, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Arya RaveendranDepartment of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India.ORCID 0000-0002-1675-0995
Teena Joseph ChackoDepartment of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India.
Priya PrabhuDepartment of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India.
Raghava VarmaDepartment of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India.
Leslie Edward LewisDepartment of Pediatrics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India.ORCID 0000-0002-3467-6821
Pragna RaoDepartment of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India.
Prajna P ShettyDepartment of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India.ORCID 0000-0002-6502-6012
Yajna S Phaneendra MallimoggalaDepartment of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India.
Asha HedgeDepartment of Pediatrics, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal 576104, India.
Dinesh M NayakDepartment of Pediatrics, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal 576104, India.
Sudeep MoorkothChesterfield Royal Hospital NHS Trust, Calow, Chesterfield S44 5BL, UK.
Sudheer MoorkothDepartment of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India.

Funding

Grand Challenges Canada R-ST-POC-1707-07275Vision group of Science and Technology, Government of Karnataka VGST/CESEM/GRD-308 (2014-15)/53/17-18/218
6 · The paper itself

Abstract

India, a country with the second largest population in the world, does not have a national newborn screening programme as part of its health policy. With funding support from the Grand Challenges Canada, a pilot newborn screening programme was implemented for the Udupi district of South India to study the need and viability of a national programme in India. Six disorders were selected for the study based on the availability of funding and recommendation from pediatricians in the district. Here, we report the observed incidence during the study. A cost-effectiveness analysis of implementing newborn screening in India was performed. It is evident from our analysis that the financial loss for the nation due to these preventable diseases is much higher than the overall expenditure for screening, diagnosis, and treatment. This cost-effectiveness analysis justifies the need for a national newborn screening programme in India.

Indexed as

awarenesscost-effectivenessincidenceIndianewborn screening

Identifiers

PMID35466197
PMCPMC9036214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.